Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993–2014

Clozapine’s critical role in treatment resistant schizophrenia: ensuring both safety and use

(2016) G. Remington et al.   Expert Opinion On Drug Safety

An update of safety of clinically used atypical antipsychotics

(2016) L. Orsolini et al.   Expert Opinion On Drug Safety

Diabetic ketoacidosis in patients exposed to antipsychotics: a systematic literature review and analysis of Danish adverse drug event reports

(2016) Christoffer Polcwiartek et al.   PSYCHOPHARMACOLOGY

Clozapine users in Australia: their characteristics and experiences of care based on data from the 2010 National Survey of High Impact Psychosis

(2016) D. J. Siskind et al.   Epidemiology and Psychiatric Sciences

Clozapine-induced myocarditis, a widely overlooked adverse reaction

(2015) K. J. Ronaldson et al.   ACTA PSYCHIATRICA SCANDINAVICA

Increasing Clozapine Dispensing Trends in Queensland, Australia 2004–2013

(2015) T. Forrester et al.   PHARMACOPSYCHIATRY

Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level

(2015) MARC DE HERT et al.   World Psychiatry

Clozapine-induced myocarditis: Separating the wheat from the chaff

(2014) Karl Winckel et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Improved Detection of Common Variants Associated with Schizophrenia by Leveraging Pleiotropy with Cardiovascular-Disease Risk Factors

(2013) Ole A. Andreassen et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Low awareness of adverse drug reaction reporting systems: a consumer survey

(2013) Jane Robertson et al.   MEDICAL JOURNAL OF AUSTRALIA

Optimising treatment of refractory schizophrenia

(2013) Katherine Beck et al.   PSYCHOPHARMACOLOGY

Sex and Gender Differences in Myocarditis and Dilated Cardiomyopathy

(2012) DeLisa Fairweather et al.   CURRENT PROBLEMS IN CARDIOLOGY

Clozapine-Induced Agranulocytosis in Finland, 1982–2007

(2012) Liisa Lahdelma et al.   JOURNAL OF CLINICAL PSYCHIATRY

Optimizing clozapine treatment

(2011) J. Nielsen et al.   ACTA PSYCHIATRICA SCANDINAVICA

Clozapine Use in Australia

(2011) Geethal Malalagama et al.   Australasian Psychiatry

An Algorithm-Based Approach to First-Episode Schizophrenia

(2011) Ofer Agid et al.   JOURNAL OF CLINICAL PSYCHIATRY

Clinical course and analysis of ten fatal cases of clozapine-induced myocarditis and comparison with 66 surviving cases

(2011) Kathlyn J. Ronaldson et al.   SCHIZOPHRENIA RESEARCH

Side-effects and treatment with clozapine: A comparison between the views of consumers and their clinicians

(2010) Kay Hodge et al.   International Journal of Mental Health Nursing

Diagnostic Characteristics of Clozapine-Induced Myocarditis Identified by an Analysis of 38 Cases and 47 Controls

(2010) Kathlyn J. Ronaldson et al.   JOURNAL OF CLINICAL PSYCHIATRY

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)

(2009) Jari Tiihonen et al.   LANCET

Sex Differences in Autoimmune Disease from a Pathological Perspective

(2008) DeLisa Fairweather et al.   AMERICAN JOURNAL OF PATHOLOGY